These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Treatments for pulmonary arterial hypertension. Liu C; Liu K; Ji Z; Liu G Respir Med; 2006 May; 100(5):765-74. PubMed ID: 16549344 [TBL] [Abstract][Full Text] [Related]
3. Treatment of pulmonary arterial hypertension. Humbert M; Sitbon O; Simonneau G N Engl J Med; 2004 Sep; 351(14):1425-36. PubMed ID: 15459304 [No Abstract] [Full Text] [Related]
4. Sildenafil treatment of primary pulmonary hypertension. Laupland KB; Helmersen D; Zygun DA; Viner SM Can Respir J; 2003; 10(1):48-50. PubMed ID: 12624621 [TBL] [Abstract][Full Text] [Related]
5. Sildenafil for treatment of lung fibrosis and pulmonary hypertension: a randomised controlled trial. Ghofrani HA; Wiedemann R; Rose F; Schermuly RT; Olschewski H; Weissmann N; Gunther A; Walmrath D; Seeger W; Grimminger F Lancet; 2002 Sep; 360(9337):895-900. PubMed ID: 12354470 [TBL] [Abstract][Full Text] [Related]
6. [The combined use of sildenafil with epoprostenol in a patient with primary pulmonary hypertension]. Kayikçioğlu M; Can LH; Payzin S; Kültürsay H; Soydan I Anadolu Kardiyol Derg; 2002 Sep; 2(3):262-4. PubMed ID: 12223337 [No Abstract] [Full Text] [Related]
7. [Hopes and experiences in the treatment of severe pulmonary hypertension]. Monserrat L; Penas Lado M; Castro-Beiras A Rev Esp Cardiol; 2003 Mar; 56(3):228-9. PubMed ID: 12622951 [No Abstract] [Full Text] [Related]
8. An evidence-based approach to the management of pulmonary arterial hypertension. Archer SL; Michelakis ED Curr Opin Cardiol; 2006 Jul; 21(4):385-92. PubMed ID: 16755209 [TBL] [Abstract][Full Text] [Related]
9. Treatment of rebound pulmonary hypertension: why not sildenafil? Raja SG Anesthesiology; 2004 Dec; 101(6):1480; author reply 1481. PubMed ID: 15564966 [No Abstract] [Full Text] [Related]
10. Clinical practice: pulmonary hypertension in children. De Wolf D Eur J Pediatr; 2009 May; 168(5):515-22. PubMed ID: 19148677 [TBL] [Abstract][Full Text] [Related]
11. Better off blue: BMPR-2 mutation, arteriovenous malformation, and pulmonary arterial hypertension. Soon E; Southwood M; Sheares K; Pepke-Zaba J; Morrell NW Am J Respir Crit Care Med; 2014 Jun; 189(11):1435-6. PubMed ID: 24881940 [No Abstract] [Full Text] [Related]
12. Marked improvement with sildenafil in a patient with primary pulmonary hypertension unresponsive to epoprostenol. Kataoka M; Satoh T; Manabe T; Anzai T; Yoshikawa T; Mitamura H; Ogawa S Intern Med; 2004 Oct; 43(10):945-50. PubMed ID: 15575245 [TBL] [Abstract][Full Text] [Related]
13. [Primary pulmonary hypertension: prospects for treatment]. Sáenz de la Calzada C Med Clin (Barc); 2004 Jan; 122(2):62-3. PubMed ID: 14733858 [No Abstract] [Full Text] [Related]
14. [Treatment with sildenafil, bosentan, or both in children and young people with idiopathic pulmonary arterial hypertension and Eisenmenger's syndrome]. Raposo-Sonnenfeld I; Otero-González I; Blanco-Aparicio M; Ferrer-Barba A; Medrano-López C Rev Esp Cardiol; 2007 Apr; 60(4):366-72. PubMed ID: 17521545 [TBL] [Abstract][Full Text] [Related]
15. Sildenafil as a treatment for pulmonary hypertension. Carroll WD; Dhillon R Arch Dis Child; 2003 Sep; 88(9):827-8. PubMed ID: 12937112 [TBL] [Abstract][Full Text] [Related]
16. Use of sildenafil with inhaled nitric oxide in the management of severe pulmonary hypertension. Saygili A; Canter B; Iriz E; Kula S; Tunaoğlu FS; Olguntürk R; Ozdoğan ME J Cardiothorac Vasc Anesth; 2004 Dec; 18(6):775-6. PubMed ID: 15650993 [No Abstract] [Full Text] [Related]
17. [The treatment of idiopathic pulmonary artery hypertension and its relation to systemic scleroderma]. Humbert M Rev Med Interne; 2007 Dec; 28 Suppl 4():S273-6. PubMed ID: 17961866 [No Abstract] [Full Text] [Related]
18. Combination drug therapy in the management of pulmonary arterial hypertension. Kayser SR Prog Cardiovasc Nurs; 2005; 20(4):177-82. PubMed ID: 16276142 [No Abstract] [Full Text] [Related]
19. Endothelin receptor expression in idiopathic pulmonary arterial hypertension: effect of bosentan and epoprostenol treatment. Hall SM; Davie N; Klein N; Haworth SG Eur Respir J; 2011 Oct; 38(4):851-60. PubMed ID: 21406517 [TBL] [Abstract][Full Text] [Related]
20. Scheduled perioperative switch from oral sildenafil to intravenous epoprostenol in a patient with Eisenmenger syndrome undergoing a sigmoidectomy. Moriyama K; Uzawa K; Iijima T; Kotani M; Moriyama K; Ohashi Y; Satoh T; Yorozu T J Clin Anesth; 2012 Sep; 24(6):487-9. PubMed ID: 22762976 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]